CeraVe Acne Control Gel is a hydrating, daily acne treatment with 2% salicylic acid that clears acne and helps prevent new breakouts from forming. It also offers gentle exfoliation with alpha- and beta-hydroxy acids (AHA and BHA) that help improve the appearance of pores along with calming niacinamide and barrier-strengthening ceramides.
This gel is a lightweight, hydrating, full-face acne treatment that is also mild yet effective. Acne Control Gel also replenishes the skin’s protective barrier with 3 essential ceramides that work together to lock in skins moisture and help restore your skin’s protective barrier, calms the skin with niacinamide, helps skin look noticeably clearer after 3 days and maintains healthy skin with daily use. MVE technology encapsulates ceramides to ensure efficient delivery within the skin’s barrier and slow release over.
INGREDIENTS
BENEFITS
- Glycolic and lactic acids (AHAs): Help even skin texture for smoother-looking skin
- Salicylic acid (BHA): Treats acne and penetrates pores to help prevent new breakouts
- MVE Technology: Provides a steady release of all-day hydration
- Ceramides: Help restore the skin’s natural barrier
- Niacinamide: Helps calm the skin
- Non-comedogenic
- Oil-, fragrance- and paraben-free
- Free of drying alcohol
- Dermatologist-tested
HOW TO USE
- Cleanse the skin thoroughly before applying this product
- Recommended for evening use
- Cover the entire affected area with a thin layer every other day
- Because excessive drying of the skin may occur, start with one application weekly, then gradually increase to two or three times if needed or as directed by a doctor
- If bothersome dryness or peeling occurs, reduce application to once a day or every other day
Sunburn Alert: This product contains an alpha-hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards.
Reviews
There are no reviews yet.